Stockreport

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Adicet Bio, Inc.  (ACET) 
Last adicet bio, inc. earnings: 5/3 05:00 pm Check Earnings Report
US:NASDAQ Investor Relations: aceto.com/ir/index.html
PDF First gamma delta CAR T cell therapy with the potential to address solid tumors entering clinical trialsPreliminary Phase 1 clinical data expected in the first half of 2 [Read more]